Results 211 to 220 of about 297,286 (321)

Growth differentiation factor 15 alters intestinal barrier and increases permeability: A new molecular target in inflammatory bowel disease. [PDF]

open access: yesWorld J Gastroenterol
Ruiz-Malagón AJ   +18 more
europepmc   +1 more source

Intracerebroventricular knockdown of NPY1R disrupts NPY1R-GALR2/TrkB heteroreceptor complexes without affecting neuroplasticity or depressive-like behaviour. [PDF]

open access: yesJ Psychopharmacol
Moreno-Madrid I   +7 more
europepmc   +1 more source

Worldwide Research Trends on Substance Use Disorder‐Related Inflammatory Imbalances: A Bibliometric Analysis

open access: yesCNS Neuroscience &Therapeutics, Volume 31, Issue 12, December 2025.
A bibliometric analysis of worldwide research trends on “substance use disorder‐related inflammation”. “Neuroinflammation” is identified as a key research hotspot. The findings provide a data‐driven overview of the evolving landscape in this field. ABSTRACT Background Substance use disorder (SUD) is a complex, chronic, and relapsing encephalopathy ...
Shirui Cao   +3 more
wiley   +1 more source

Assessment of Long-Term Mild and Major Neurocognitive Disorders 48 Months After Cardiac Surgery. [PDF]

open access: yesInt J Geriatr Psychiatry
Florido-Santiago M   +9 more
europepmc   +1 more source

Eco‐Friendly Mechanochemical Approach to Magnetic Graphene Oxide: A High‐Efficiency Sorbent for Environmental Pollutant Removal

open access: yesGlobal Challenges, Volume 9, Issue 12, December 2025.
The proposed nanomaterial is mechanochemically synthesized, avoiding strong acids and hazardous oxidants. Magnetic graphene oxide (d‐M@GO) is an excellent adsorbent towards metal ions and per/polyfluoroalkyl compounds (PFAS), with fast kinetics and high reusability.
Pablo Montoro‐Leal   +5 more
wiley   +1 more source

Impact of Nutritional Status on Severe Radiation-Induced Mucositis in Oropharyngeal Cancer Patients Undergoing Chemo-Radiotherapy. [PDF]

open access: yesNutrients
Fernández-Forné Á   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy